ID   PDE2A_HUMAN             Reviewed;         941 AA.
AC   O00408; B2R646; B3KRV5; E9PGI1; F6W5Z0; Q5J791; Q5J792; Q5J793;
AC   Q6ZMR1;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   22-JUL-2015, entry version 137.
DE   RecName: Full=cGMP-dependent 3',5'-cyclic phosphodiesterase;
DE            EC=3.1.4.17;
DE   AltName: Full=Cyclic GMP-stimulated phosphodiesterase;
DE            Short=CGS-PDE;
DE            Short=cGSPDE;
GN   Name=PDE2A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PDE2A3).
RC   TISSUE=Fetal brain, and Hippocampus;
RX   PubMed=9210593; DOI=10.1016/S0378-1119(97)00046-2;
RA   Rosman G.J., Martins T.J., Sonnenburg W.K., Beavo J.A., Ferguson K.,
RA   Loughney K.;
RT   "Isolation and characterization of human cDNAs encoding a cGMP-
RT   stimulated 3',5'-cyclic nucleotide phosphodiesterase.";
RL   Gene 191:89-95(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PDE2A4), NUCLEOTIDE SEQUENCE
RP   [MRNA] OF 1-27 (ISOFORM PDE2A1), AND NUCLEOTIDE SEQUENCE [MRNA] OF
RP   1-55 (ISOFORM PDE2A2).
RA   Bugaj-Gaweda B., De Vivo M., Wang D.;
RT   "Human PDE2A1, PDE2A2 and PDE2A4.";
RL   Submitted (DEC-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS PDE2A3; 5 AND 6).
RC   TISSUE=Adrenal gland, Brain, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [5]
RP   MYRISTOYLATION AT GLY-2, PALMITOYLATION AT CYS-5 AND CYS-11, AND
RP   SUBCELLULAR LOCATION (ISOFORMS PDE2A1 AND PDE2A3).
RX   PubMed=19632989; DOI=10.1074/jbc.M109.017194;
RA   Russwurm C., Zoidl G., Koesling D., Russwurm M.;
RT   "Dual acylation of PDE2A splice variant 3: targeting to synaptic
RT   membranes.";
RL   J. Biol. Chem. 284:25782-25790(2009).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [7]
RP   MYRISTOYLATION AT GLY-2.
RX   PubMed=20213681; DOI=10.1002/pmic.200900783;
RA   Suzuki T., Moriya K., Nagatoshi K., Ota Y., Ezure T., Ando E.,
RA   Tsunasawa S., Utsumi T.;
RT   "Strategy for comprehensive identification of human N-myristoylated
RT   proteins using an insect cell-free protein synthesis system.";
RL   Proteomics 10:1780-1793(2010).
RN   [8]
RP   FUNCTION (ISOFORM PDE2A2), AND SUBCELLULAR LOCATION (ISOFORM PDE2A2).
RX   PubMed=21724846; DOI=10.1074/jbc.M111.266379;
RA   Acin-Perez R., Russwurm M., Gunnewig K., Gertz M., Zoidl G., Ramos L.,
RA   Buck J., Levin L.R., Rassow J., Manfredi G., Steegborn C.;
RT   "A phosphodiesterase 2A isoform localized to mitochondria regulates
RT   respiration.";
RL   J. Biol. Chem. 286:30423-30432(2011).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 578-919 IN COMPLEX WITH
RP   METAL IONS AND PHOSPHATE, AND FUNCTION.
RX   PubMed=15938621; DOI=10.1021/bi047313h;
RA   Iffland A., Kohls D., Low S., Luan J., Zhang Y., Kothe M., Cao Q.,
RA   Kamath A.V., Ding Y.H., Ellenberger T.;
RT   "Structural determinants for inhibitor specificity and selectivity in
RT   PDE2A using the wheat germ in vitro translation system.";
RL   Biochemistry 44:8312-8325(2005).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.58 ANGSTROMS) OF 215-919 IN COMPLEX WITH
RP   METAL IONS AND THE INHIBITOR IBMX, SUBUNIT, AND FUNCTION.
RX   PubMed=19828435; DOI=10.1073/pnas.0907635106;
RA   Pandit J., Forman M.D., Fennell K.F., Dillman K.S., Menniti F.S.;
RT   "Mechanism for the allosteric regulation of phosphodiesterase 2A
RT   deduced from the X-ray structure of a near full-length construct.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:18225-18230(2009).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 578-919 IN COMPLEX WITH
RP   INHIBITOR.
RX   PubMed=23899287; DOI=10.1021/ja404449g;
RA   Zhu J., Yang Q., Dai D., Huang Q.;
RT   "X-ray crystal structure of phosphodiesterase 2 in complex with a
RT   highly selective, nanomolar inhibitor reveals a binding-induced pocket
RT   important for selectivity.";
RL   J. Am. Chem. Soc. 135:11708-11711(2013).
CC   -!- FUNCTION: Cyclic nucleotide phosphodiesterase with a dual-
CC       specificity for the second messengers cAMP and cGMP, which are key
CC       regulators of many important physiological processes.
CC   -!- FUNCTION: Isoform PDE2A2: Regulates Mitochondrial cAMP Levels and
CC       Respiration.
CC   -!- CATALYTIC ACTIVITY: Nucleoside 3',5'-cyclic phosphate + H(2)O =
CC       nucleoside 5'-phosphate.
CC   -!- COFACTOR:
CC       Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;
CC         Evidence={ECO:0000250};
CC       Note=Binds 2 divalent metal cations per subunit. Site 1 may
CC       preferentially bind zinc ions, while site 2 has a preference for
CC       magnesium and/or manganese ions. {ECO:0000250};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:15938621,
CC       ECO:0000269|PubMed:19828435, ECO:0000269|PubMed:23899287}.
CC   -!- INTERACTION:
CC       O00170:AIP; NbExp=6; IntAct=EBI-1785967, EBI-704197;
CC   -!- SUBCELLULAR LOCATION: Isoform PDE2A3: Cell membrane
CC       {ECO:0000269|PubMed:19632989}; Lipid-anchor
CC       {ECO:0000269|PubMed:19632989}.
CC   -!- SUBCELLULAR LOCATION: Isoform PDE2A2: Mitochondrion matrix
CC       {ECO:0000269|PubMed:21724846}.
CC   -!- SUBCELLULAR LOCATION: Isoform PDE2A1: Cytoplasm
CC       {ECO:0000269|PubMed:19632989}.
CC   -!- SUBCELLULAR LOCATION: Isoform 5: Mitochondrion {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC         Comment=Additional isoforms seem to exist. Experimental
CC         confirmation may be lacking for some isoforms.;
CC       Name=PDE2A3;
CC         IsoId=O00408-1; Sequence=Displayed;
CC       Name=PDE2A1;
CC         IsoId=O00408-2; Sequence=VSP_055315;
CC         Note=Soluble form.;
CC       Name=PDE2A2;
CC         IsoId=O00408-3; Sequence=VSP_055316;
CC         Note=Contains a transit peptide at positions 1-17.;
CC       Name=PDE2A4;
CC         IsoId=O00408-4; Sequence=VSP_055317;
CC       Name=5;
CC         IsoId=O00408-5; Sequence=VSP_055316, VSP_055318;
CC         Note=No experimental confirmation available.;
CC       Name=6;
CC         IsoId=O00408-6; Sequence=VSP_055315, VSP_055319, VSP_055320;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in brain and to a lesser extent in
CC       heart, placenta, lung, skeletal muscle, kidney and pancreas.
CC   -!- DOMAIN: GAF 1 functions as a dimerization domain, whereas GAF 2
CC       binds cGMP, which causes activation of the catalytic activity of
CC       the enzyme. {ECO:0000250}.
CC   -!- MISCELLANEOUS: cGMP binds at an allosteric activator site.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterase
CC       family. PDE2 subfamily. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 2 GAF domains. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAS75515.1; Type=Frameshift; Positions=48; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U67733; AAC51320.1; -; mRNA.
DR   EMBL; AY495087; AAS75513.1; -; mRNA.
DR   EMBL; AY495088; AAS75514.1; -; mRNA.
DR   EMBL; AY495089; AAS75515.1; ALT_FRAME; mRNA.
DR   EMBL; AK092278; BAG52517.1; -; mRNA.
DR   EMBL; AK131525; BAD18664.1; -; mRNA.
DR   EMBL; AK312434; BAG35343.1; -; mRNA.
DR   EMBL; AP003065; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP005019; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS44670.1; -. [O00408-3]
DR   CCDS; CCDS53678.1; -. [O00408-4]
DR   CCDS; CCDS73345.1; -. [O00408-2]
DR   CCDS; CCDS8216.1; -. [O00408-1]
DR   RefSeq; NP_001137311.1; NM_001143839.3. [O00408-3]
DR   RefSeq; NP_001139681.1; NM_001146209.2. [O00408-4]
DR   RefSeq; NP_001230713.1; NM_001243784.1. [O00408-2]
DR   RefSeq; NP_002590.1; NM_002599.4. [O00408-1]
DR   UniGene; Hs.503163; -.
DR   PDB; 1Z1L; X-ray; 1.70 A; A=578-919.
DR   PDB; 3IBJ; X-ray; 3.02 A; A/B=215-900.
DR   PDB; 3ITM; X-ray; 2.49 A; A/B/C/D=579-919.
DR   PDB; 3ITU; X-ray; 1.58 A; A/B/C/D=579-919.
DR   PDB; 4C1I; X-ray; 2.40 A; A/B/C/D=578-921.
DR   PDB; 4D08; X-ray; 1.90 A; A/B/C/D=578-921.
DR   PDB; 4D09; X-ray; 2.50 A; A/B/C/D=578-921.
DR   PDB; 4HTX; X-ray; 1.90 A; A/B/C/D=578-919.
DR   PDB; 4HTZ; X-ray; 2.00 A; A/B/C/D=578-919.
DR   PDB; 4JIB; X-ray; 1.72 A; A/B/C/D=579-919.
DR   PDBsum; 1Z1L; -.
DR   PDBsum; 3IBJ; -.
DR   PDBsum; 3ITM; -.
DR   PDBsum; 3ITU; -.
DR   PDBsum; 4C1I; -.
DR   PDBsum; 4D08; -.
DR   PDBsum; 4D09; -.
DR   PDBsum; 4HTX; -.
DR   PDBsum; 4HTZ; -.
DR   PDBsum; 4JIB; -.
DR   ProteinModelPortal; O00408; -.
DR   SMR; O00408; 223-916.
DR   BioGrid; 111164; 3.
DR   DIP; DIP-40269N; -.
DR   IntAct; O00408; 3.
DR   STRING; 9606.ENSP00000334910; -.
DR   BindingDB; O00408; -.
DR   ChEMBL; CHEMBL2652; -.
DR   DrugBank; DB00201; Caffeine.
DR   DrugBank; DB08811; Tofisopam.
DR   GuidetoPHARMACOLOGY; 1297; -.
DR   PhosphoSite; O00408; -.
DR   BioMuta; PDE2A; -.
DR   MaxQB; O00408; -.
DR   PaxDb; O00408; -.
DR   PRIDE; O00408; -.
DR   Ensembl; ENST00000334456; ENSP00000334910; ENSG00000186642.
DR   Ensembl; ENST00000376450; ENSP00000365633; ENSG00000186642. [O00408-5]
DR   Ensembl; ENST00000444035; ENSP00000411657; ENSG00000186642. [O00408-2]
DR   Ensembl; ENST00000540345; ENSP00000446399; ENSG00000186642. [O00408-4]
DR   Ensembl; ENST00000544570; ENSP00000442256; ENSG00000186642. [O00408-3]
DR   GeneID; 5138; -.
DR   KEGG; hsa:5138; -.
DR   UCSC; uc010rrb.2; human. [O00408-4]
DR   UCSC; uc010rrc.2; human. [O00408-1]
DR   CTD; 5138; -.
DR   GeneCards; GC11M072287; -.
DR   HGNC; HGNC:8777; PDE2A.
DR   HPA; CAB009752; -.
DR   MIM; 602658; gene.
DR   neXtProt; NX_O00408; -.
DR   PharmGKB; PA33125; -.
DR   eggNOG; NOG270709; -.
DR   GeneTree; ENSGT00760000119066; -.
DR   HOGENOM; HOG000007068; -.
DR   HOVERGEN; HBG053540; -.
DR   KO; K18283; -.
DR   OMA; RAPINGC; -.
DR   OrthoDB; EOG767393; -.
DR   PhylomeDB; O00408; -.
DR   TreeFam; TF316499; -.
DR   BRENDA; 3.1.4.17; 2681.
DR   Reactome; REACT_19327; G alpha (s) signalling events.
DR   Reactome; REACT_23767; cGMP effects.
DR   ChiTaRS; PDE2A; human.
DR   EvolutionaryTrace; O00408; -.
DR   GeneWiki; PDE2A; -.
DR   GenomeRNAi; 5138; -.
DR   NextBio; 19812; -.
DR   PRO; PR:O00408; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; O00408; -.
DR   CleanEx; HS_PDE2A; -.
DR   ExpressionAtlas; O00408; baseline and differential.
DR   Genevisible; O00408; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; IEA:Ensembl.
DR   GO; GO:0005759; C:mitochondrial matrix; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0042734; C:presynaptic membrane; ISS:UniProtKB.
DR   GO; GO:0005262; F:calcium channel activity; TAS:UniProtKB.
DR   GO; GO:0030552; F:cAMP binding; IMP:UniProtKB.
DR   GO; GO:0030553; F:cGMP binding; IDA:UniProtKB.
DR   GO; GO:0004118; F:cGMP-stimulated cyclic-nucleotide phosphodiesterase activity; IDA:UniProtKB.
DR   GO; GO:0004112; F:cyclic-nucleotide phosphodiesterase activity; IDA:UniProtKB.
DR   GO; GO:0008144; F:drug binding; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0030911; F:TPR domain binding; IPI:UniProtKB.
DR   GO; GO:0007596; P:blood coagulation; TAS:Reactome.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; TAS:GOC.
DR   GO; GO:0006198; P:cAMP catabolic process; IDA:UniProtKB.
DR   GO; GO:0019933; P:cAMP-mediated signaling; IMP:UniProtKB.
DR   GO; GO:0071321; P:cellular response to cGMP; IDA:UniProtKB.
DR   GO; GO:0035690; P:cellular response to drug; IMP:UniProtKB.
DR   GO; GO:0097011; P:cellular response to granulocyte macrophage colony-stimulating factor stimulus; IDA:UniProtKB.
DR   GO; GO:0036006; P:cellular response to macrophage colony-stimulating factor stimulus; IDA:UniProtKB.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; ISS:UniProtKB.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEP:UniProtKB.
DR   GO; GO:0046069; P:cGMP catabolic process; IDA:UniProtKB.
DR   GO; GO:0019934; P:cGMP-mediated signaling; IMP:UniProtKB.
DR   GO; GO:0061028; P:establishment of endothelial barrier; ISS:UniProtKB.
DR   GO; GO:0008152; P:metabolic process; IDA:UniProtKB.
DR   GO; GO:0030224; P:monocyte differentiation; IEP:UniProtKB.
DR   GO; GO:0030818; P:negative regulation of cAMP biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0033159; P:negative regulation of protein import into nucleus, translocation; IDA:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0043116; P:negative regulation of vascular permeability; IMP:UniProtKB.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:0043117; P:positive regulation of vascular permeability; IMP:UniProtKB.
DR   GO; GO:0006626; P:protein targeting to mitochondrion; ISS:UniProtKB.
DR   Gene3D; 1.10.1300.10; -; 1.
DR   Gene3D; 3.30.450.40; -; 2.
DR   InterPro; IPR003018; GAF.
DR   InterPro; IPR029016; GAF_dom-like.
DR   InterPro; IPR003607; HD/PDEase_dom.
DR   InterPro; IPR023088; PDEase.
DR   InterPro; IPR002073; PDEase_catalytic_dom.
DR   InterPro; IPR023174; PDEase_CS.
DR   Pfam; PF01590; GAF; 2.
DR   Pfam; PF00233; PDEase_I; 1.
DR   PRINTS; PR00387; PDIESTERASE1.
DR   SMART; SM00065; GAF; 2.
DR   SMART; SM00471; HDc; 1.
DR   SUPFAM; SSF55781; SSF55781; 3.
DR   PROSITE; PS00126; PDEASE_I; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; cAMP; Cell membrane; cGMP;
KW   cGMP-binding; Complete proteome; Cytoplasm; Hydrolase; Lipoprotein;
KW   Membrane; Metal-binding; Mitochondrion; Myristate; Nucleotide-binding;
KW   Palmitate; Polymorphism; Reference proteome; Repeat.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    941       cGMP-dependent 3',5'-cyclic
FT                                phosphodiesterase.
FT                                /FTId=PRO_0000198796.
FT   DOMAIN      241    377       GAF 1.
FT   DOMAIN      409    548       GAF 2.
FT   REGION      633    891       Catalytic. {ECO:0000250}.
FT   REGION      656    660       Substrate binding.
FT   ACT_SITE    656    656       Proton donor. {ECO:0000250}.
FT   METAL       660    660       Divalent metal cation 1.
FT   METAL       696    696       Divalent metal cation 1.
FT   METAL       697    697       Divalent metal cation 1.
FT   METAL       697    697       Divalent metal cation 2.
FT   METAL       808    808       Divalent metal cation 1.
FT   BINDING     431    431       cGMP. {ECO:0000250}.
FT   BINDING     446    446       cGMP. {ECO:0000250}.
FT   BINDING     499    499       cGMP. {ECO:0000250}.
FT   BINDING     697    697       Substrate.
FT   BINDING     808    808       Substrate.
FT   LIPID         2      2       N-myristoyl glycine.
FT                                {ECO:0000269|PubMed:19632989,
FT                                ECO:0000269|PubMed:20213681}.
FT   LIPID         5      5       S-palmitoyl cysteine; in isoform PDE2A3.
FT                                {ECO:0000305|PubMed:19632989}.
FT   LIPID        11     11       S-palmitoyl cysteine; in isoform PDE2A3.
FT                                {ECO:0000305|PubMed:19632989}.
FT   VAR_SEQ       1     48       MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQ
FT                                PCADSLQ -> MRRQPAASLDPLAKEPGPPGSRDDRLE
FT                                (in isoform PDE2A1 and isoform 6).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_055315.
FT   VAR_SEQ       1     24       MGQACGHSILCRSQQYPAARPAEP -> MVLVLHHILIAVV
FT                                QFLR (in isoform PDE2A2 and isoform 5).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_055316.
FT   VAR_SEQ       1     24       MGQACGHSILCRSQQYPAARPAEP -> MKKQRIQEGKSLA
FT                                HR (in isoform PDE2A4).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_055317.
FT   VAR_SEQ     109    357       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055318.
FT   VAR_SEQ     750    807       SRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDR
FT                                NNKQHHRLLLCLLMTSC -> PLRTTTILMVGLGPGGYRGP
FT                                RKKLPEGQLSALQRGALGRSRMGLMGRRDPRTGRQAQV
FT                                (in isoform 6).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055319.
FT   VAR_SEQ     808    941       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055320.
FT   VARIANT     224    224       T -> I (in dbSNP:rs341047).
FT                                /FTId=VAR_024170.
FT   CONFLICT     38     38       P -> L (in Ref. 2; AAS75513).
FT                                {ECO:0000305}.
FT   CONFLICT     99     99       H -> R (in Ref. 3; BAG35343).
FT                                {ECO:0000305}.
FT   CONFLICT    213    213       T -> A (in Ref. 2; AAS75513).
FT                                {ECO:0000305}.
FT   CONFLICT    664    664       V -> A (in Ref. 2; AAS75513).
FT                                {ECO:0000305}.
FT   HELIX       226    236       {ECO:0000244|PDB:3IBJ}.
FT   HELIX       242    256       {ECO:0000244|PDB:3IBJ}.
FT   STRAND      262    267       {ECO:0000244|PDB:3IBJ}.
FT   STRAND      271    279       {ECO:0000244|PDB:3IBJ}.
FT   STRAND      282    291       {ECO:0000244|PDB:3IBJ}.
FT   STRAND      294    296       {ECO:0000244|PDB:3IBJ}.
FT   HELIX       297    302       {ECO:0000244|PDB:3IBJ}.
FT   HELIX       308    310       {ECO:0000244|PDB:3IBJ}.
FT   HELIX       313    323       {ECO:0000244|PDB:3IBJ}.
FT   STRAND      330    336       {ECO:0000244|PDB:3IBJ}.
FT   STRAND      338    340       {ECO:0000244|PDB:3IBJ}.
FT   STRAND      342    355       {ECO:0000244|PDB:3IBJ}.
FT   HELIX       362    403       {ECO:0000244|PDB:3IBJ}.
FT   TURN        410    412       {ECO:0000244|PDB:3IBJ}.
FT   HELIX       413    425       {ECO:0000244|PDB:3IBJ}.
FT   STRAND      427    435       {ECO:0000244|PDB:3IBJ}.
FT   STRAND      437    443       {ECO:0000244|PDB:3IBJ}.
FT   STRAND      446    448       {ECO:0000244|PDB:3IBJ}.
FT   STRAND      456    460       {ECO:0000244|PDB:3IBJ}.
FT   HELIX       464    472       {ECO:0000244|PDB:3IBJ}.
FT   STRAND      476    479       {ECO:0000244|PDB:3IBJ}.
FT   STRAND      502    506       {ECO:0000244|PDB:3IBJ}.
FT   STRAND      510    512       {ECO:0000244|PDB:3IBJ}.
FT   STRAND      516    528       {ECO:0000244|PDB:3IBJ}.
FT   TURN        531    534       {ECO:0000244|PDB:3IBJ}.
FT   HELIX       535    570       {ECO:0000244|PDB:3IBJ}.
FT   TURN        571    573       {ECO:0000244|PDB:3IBJ}.
FT   HELIX       580    587       {ECO:0000244|PDB:3ITU}.
FT   HELIX       593    595       {ECO:0000244|PDB:3ITU}.
FT   TURN        598    601       {ECO:0000244|PDB:3ITU}.
FT   HELIX       607    609       {ECO:0000244|PDB:3ITU}.
FT   HELIX       612    614       {ECO:0000244|PDB:3ITU}.
FT   HELIX       615    625       {ECO:0000244|PDB:3ITU}.
FT   HELIX       628    631       {ECO:0000244|PDB:3ITU}.
FT   HELIX       636    648       {ECO:0000244|PDB:3ITU}.
FT   STRAND      654    657       {ECO:0000244|PDB:3ITU}.
FT   HELIX       658    675       {ECO:0000244|PDB:3ITU}.
FT   HELIX       677    679       {ECO:0000244|PDB:3ITU}.
FT   HELIX       683    695       {ECO:0000244|PDB:3ITU}.
FT   TURN        696    699       {ECO:0000244|PDB:3ITU}.
FT   HELIX       705    710       {ECO:0000244|PDB:3ITU}.
FT   HELIX       714    719       {ECO:0000244|PDB:3ITU}.
FT   TURN        720    722       {ECO:0000244|PDB:3ITU}.
FT   HELIX       725    738       {ECO:0000244|PDB:3ITU}.
FT   TURN        741    743       {ECO:0000244|PDB:3IBJ}.
FT   TURN        745    748       {ECO:0000244|PDB:3ITU}.
FT   HELIX       751    766       {ECO:0000244|PDB:3ITU}.
FT   HELIX       770    786       {ECO:0000244|PDB:3ITU}.
FT   HELIX       793    808       {ECO:0000244|PDB:3ITU}.
FT   HELIX       810    813       {ECO:0000244|PDB:3ITU}.
FT   HELIX       816    839       {ECO:0000244|PDB:3ITU}.
FT   HELIX       846    848       {ECO:0000244|PDB:3ITU}.
FT   TURN        850    852       {ECO:0000244|PDB:3ITU}.
FT   HELIX       855    865       {ECO:0000244|PDB:3ITU}.
FT   HELIX       867    877       {ECO:0000244|PDB:3ITU}.
FT   HELIX       879    881       {ECO:0000244|PDB:3ITU}.
FT   HELIX       882    898       {ECO:0000244|PDB:3ITU}.
FT   HELIX       899    902       {ECO:0000244|PDB:3ITU}.
FT   STRAND      904    906       {ECO:0000244|PDB:1Z1L}.
FT   HELIX       914    916       {ECO:0000244|PDB:4D08}.
SQ   SEQUENCE   941 AA;  105717 MW;  9797609B487FD64E CRC64;
     MGQACGHSIL CRSQQYPAAR PAEPRGQQVF LKPDEPPPPP QPCADSLQDA LLSLGSVIDI
     SGLQRAVKEA LSAVLPRVET VYTYLLDGES QLVCEDPPHE LPQEGKVREA IISQKRLGCN
     GLGFSDLPGK PLARLVAPLA PDTQVLVMPL ADKEAGAVAA VILVHCGQLS DNEEWSLQAV
     EKHTLVALRR VQVLQQRGPR EAPRAVQNPP EGTAEDQKGG AAYTDRDRKI LQLCGELYDL
     DASSLQLKVL QYLQQETRAS RCCLLLVSED NLQLSCKVIG DKVLGEEVSF PLTGCLGQVV
     EDKKSIQLKD LTSEDVQQLQ SMLGCELQAM LCVPVISRAT DQVVALACAF NKLEGDLFTD
     EDEHVIQHCF HYTSTVLTST LAFQKEQKLK CECQALLQVA KNLFTHLDDV SVLLQEIITE
     ARNLSNAEIC SVFLLDQNEL VAKVFDGGVV DDESYEIRIP ADQGIAGHVA TTGQILNIPD
     AYAHPLFYRG VDDSTGFRTR NILCFPIKNE NQEVIGVAEL VNKINGPWFS KFDEDLATAF
     SIYCGISIAH SLLYKKVNEA QYRSHLANEM MMYHMKVSDD EYTKLLHDGI QPVAAIDSNF
     ASFTYTPRSL PEDDTSMAIL SMLQDMNFIN NYKIDCPTLA RFCLMVKKGY RDPPYHNWMH
     AFSVSHFCYL LYKNLELTNY LEDIEIFALF ISCMCHDLDH RGTNNSFQVA SKSVLAALYS
     SEGSVMERHH FAQAIAILNT HGCNIFDHFS RKDYQRMLDL MRDIILATDL AHHLRIFKDL
     QKMAEVGYDR NNKQHHRLLL CLLMTSCDLS DQTKGWKTTR KIAELIYKEF FSQGDLEKAM
     GNRPMEMMDR EKAYIPELQI SFMEHIAMPI YKLLQDLFPK AAELYERVAS NREHWTKVSH
     KFTIRGLPSN NSLDFLDEEY EVPDLDGTRA PINGCCSLDA E
//
